| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $86.5M | -8.1% |
| Cost of Revenue | $36.6M | -6.9% |
| Gross Profit | $49.9M | -8.9% |
| R&D Expense | $8.8M | -15.2% |
| SG&A Expense | $17.7M | -17.5% |
| Operating Income | -$48.6M | -682.2% |
| Interest Expense | $3.6M | +12.5% |
| Pre-tax Income | -$57.4M | -392.0% |
| Income Tax | -$686K | -192.7% |
| Net Income | -$56.7M | -357.1% |
| EPS (Basic) | -$1.28 | -357.1% |
| EPS (Diluted) | -$1.28 | -357.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | +109.7% |
| Accounts Receivable | $16.0M | +7.9% |
| Inventory | $20.8M | -10.5% |
| Current Assets | $48.2M | +6.9% |
| Total Assets | $80.1M | -36.8% |
| Current Liabilities | $22.0M | -60.0% |
| Long-term Debt | $35.9M | -2.9% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.7M | +367.3% |
| Capital Expenditures | $1.3M | -52.4% |
| Investing Cash Flow | -$1.9M | -38.6% |
| Financing Cash Flow | -$1.3M | -885.5% |
| Free Cash Flow | $5.5M | +554.4% |
| $66.3M |
| +4.8% |
| Stockholders' Equity | $13.7M | -78.3% |